title: Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?
authors.affiliation: Department of Transplantation, Rabin Medical Center, Petach-Tikva, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Mor
authors.forename: S
authors.initials: S
authors.lastname: Lustig
authors.forename: A
authors.initials: A
authors.lastname: Tovar
authors.forename: N
authors.initials: N
authors.lastname: Bar-Nathan
authors.forename: E
authors.initials: E
authors.lastname: Shharabani
authors.forename: Z
authors.initials: Z
authors.lastname: Shapira
authors.forename: A
authors.initials: A
authors.lastname: Yusim
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D016238:Cytapheresis; D003937:Diagnosis, Differential; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis* / Q000628:therapy; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D016030:Kidney Transplantation / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies
chemical_list: D016572:Cyclosporine